CTLA4 and neoplasm: Consequently, the ratios of CTLs to Tregs and to Arg1+ MDSC were significantly enhanced with the triple combination therapy of ML-RR-CDA administration into the flank tumor combined with systemic α-PD-1 and α-CTLA-4.